|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2007-2-26
|
|
pubmed:abstractText |
Ongoing oral anticoagulation (OA) contraindicates transurethral electroresection of the prostate. We evaluated the safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing OA with coumarin derivatives, aspirin, or clopidogrel, complaining of symptomatic benign prostatic hyperplasia (BPH).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0302-2838
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
51
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1031-8; discussion 1038-41
|
|
pubmed:meshHeading |
pubmed-meshheading:16945475-Administration, Oral,
pubmed-meshheading:16945475-Aged,
pubmed-meshheading:16945475-Aged, 80 and over,
pubmed-meshheading:16945475-Anticoagulants,
pubmed-meshheading:16945475-Follow-Up Studies,
pubmed-meshheading:16945475-Humans,
pubmed-meshheading:16945475-Male,
pubmed-meshheading:16945475-Middle Aged,
pubmed-meshheading:16945475-Prospective Studies,
pubmed-meshheading:16945475-Prostatic Hyperplasia,
pubmed-meshheading:16945475-Risk Factors,
pubmed-meshheading:16945475-Safety,
pubmed-meshheading:16945475-Transurethral Resection of Prostate
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation.
|
|
pubmed:affiliation |
Department of Urology, University Hospital Basel, Basel, Switzerland. rruszat@uhbs.ch
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
